Rhoen Klinikum AG (WBO:RHK) Tariff Resilience Score: 8/10 (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:RHK Rhoen Klinikum AG WBO:RHK
81 GF Score
Price €12.70
GF Value €13.57
! 3 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG Tariff Resilience Score?

Rhoen Klinikum AG WBO:RHK -0.78% 81 Tariff Resilience Score is 8 as of Jul. 29, 2026. GuruFocus rates WBO:RHK with a GF Score™ of 81/100 and a GF Value™ of €13.57. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks better than 96.56% on this metric.

Rhoen Klinikum AG has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Rhoen Klinikum AG has Healthcare provider with limited direct exposure to tariffs. Primarily operates within Germany, reducing international trade dependencies. Some indirect effects possible through medical equipment imports.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Rhoen Klinikum AG might have Highly Resilient.

Rhoen Klinikum AG  (WBO:RHK) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Rhoen Klinikum AG Tariff Resilience Score Related Terms

WBO:RHK vs HCA, THC, DVA: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhoen Klinikum AG Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's Tariff Resilience Score falls into.


WBO:RHK
81GF Score
Rhoen Klinikum AG WBO:RHK
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Rhoen Klinikum AG (WBO:RHK) has a Tariff Resilience Score of 8 as of Jul. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Rhoen Klinikum AG ranks #23 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 3.4%.
Is Rhoen Klinikum AG's Tariff Resilience Score too high?
Rhoen Klinikum AG's current Tariff Resilience Score is 8. Based on the distribution chart, Rhoen Klinikum AG ranks #23 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Rhoen Klinikum AG has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Tariff Resilience Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #23 out of 668 companies for Tariff Resilience Score. This places Rhoen Klinikum AG in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Rhoen Klinikum AG's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current Tariff Resilience Score of 8. The stock's GF Value™ is €13.57, compared to a current price of €12.70 — trading 6.4% below its estimated fair value. The current Tariff Resilience Score is 8. Rhoen Klinikum AG's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current Tariff Resilience Score is 8 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued. The current stock price of €12.70 is trading 6.4% below its estimated GF Value™ of €13.57.

Key valuation signals for WBO:RHK:

  • Tariff Resilience Score: 8
  • GF Value™: €13.57 vs. price of €12.70 (6.4% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
81GF Score

Get the complete analysis for WBO:RHK

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.70
Price
€13.57
GF Value